COVID-19
Informes Científicos CHEQUEADOS

América Latina Investiga

Artículos recientes publicados por colecciones de revistas científicas biomédicas de América Latina.
La información se presenta en castellano, portugués o inglés, según fuera publicada por los editores o registrada en las bases de datos.
La mayoría de los artículos enlaza con los textos completos y gratuitos de las revistas.
Los trabajos fueron provistos por sus editores o seleccionados por SIIC en recursos documentarios de la región: Scielo, Lilacs, BVS, WHO Iris, Lis, PAHO Iris, SIIC Data Bases y otros.

 
Noticiando pré-prints sobre a COVID-19: a ciência rápida em jornais dos Estados Unidos, Reino Unido e Brasil
Reporting COVID-19 preprints: fast science in newspapers in the United States, the United Kingdom and Brazil

Massarani, Luisa; Fiocruz. Casa de Oswaldo Cruz. Instituto Nacional de Comunicação Pública da Ciência e Tecnologia. Rio de Janeiro. BR, Neves, Luiz Felipe Fernandes; Fiocruz. Instituto Oswaldo Cruz. Rio de Janeiro. BR


Fuente científica: Ciênc. Saúde Colet

Fecha de actualización: 6 Abril, 2022

Resumo A pandemia COVID-19 acelerou o ritmo da ciência. Muitos dados científicos são publicados em repositórios de pré-print, antes da revisão por pares, o que levanta questionamentos sobre a credibilidade das informações ainda não validadas por outros cientistas. Analisamos 76 matérias publicadas de janeiro a julho de 2020 por três jornais (The New York Times - EUA, The Guardian - Reino Unido e Folha de S. Paulo - Brasil), que tiveram como tema estudos sobre COVID-19 publicados em plataformas de pré-print. O objetivo foi analisar como a mídia cobriu pesquisas não revisadas por pares, em países marcados por discursos conflitantes motivados pelo negacionismo de seus governantes. Os resultados mostram que os jornais não fornecem explicações detalhadas sobre o que é uma plataforma de pré-print, como funciona o processo de publicação de resultados de pesquisas e as implicações de um estudo que ainda não foi revisado por pares. A análise também revela como esses veículos foram guiados pela ansiedade gerada por uma doença desconhecida, com foco em pesquisas sobre testes de medicamentos e soroprevalência. O estudo nos leva a refletir sobre os desafios e fragilidades na cobertura de uma ciência rápida e a necessidade de ampliar a compreensão do público sobre os métodos e processos da ciência.

Abstract The COVID-19 pandemic accelerated the pace of science. Many scientific data are published on preprint repositories, prior to peer review, which raises questions about the credibility of the information not yet validated by other scientists. We analyzed 76 stories published from January to July 2020 by three newspapers (The New York Times - USA, The Guardian - UK and Folha de S. Paulo - Brazil), having as topic studies on COVID-19 published on preprint platforms. The objective was to analyze how the media covered non-peer-reviewed research, in countries marked by conflicting discourses prompted by the denialist attitude of their government leaders. The results show that the newspapers did not provide a detailed explanation of what a preprint platform is, how the process of publishing research results works, and the implications of a study that has not yet been peer reviewed. The analysis also reveals how these news outlets were guided by the anxiety from an unknown disease, focusing on research on drug trials and seroprevalence. The study leads us to reflect on the challenges and weaknesses of covering fast science and the need to broaden the public's understanding of the methods and processes of science.

Palabras clave: COVID-19, COVID-19, Comunicação e divulgação científica, Jornalismo científico, Preprint, Pré-publicação, Scientific communication and diffusion, Scientific journalism

Impacto da pandemia do COVID-19 na vacinação de crianças de até um ano de idade: um estudo ecológico
Impact of the COVID-19 pandemic on the vaccination of children 12 months of age and under: an ecological study

Procianoy, Guilherme Silveira; Universidade Federal de Ciências da Saúde de Porto Alegre. Departamento de Saúde Coletiva. Porto Alegre. BR, Rossini Junior, Fabiano; Universidade Federal de Ciências da Saúde de Porto Alegre. Departamento de Saúde Coletiva. Porto Alegre. BR, Leer más
Lied, Anita Faccini; Universidade Federal de Ciências da Saúde de Porto Alegre. Departamento de Saúde Coletiva. Porto Alegre. BR, Jung, Luís Fernando Pagliaro Probst; Universidade Federal de Ciências da Saúde de Porto Alegre. Departamento de Saúde Coletiva. Porto Alegre. BR, Souza, Maria Cláudia Schardosim Cotta de; Universidade Federal de Ciências da Saúde de Porto Alegre. Departamento de Saúde Coletiva. Porto Alegre. BR



Fuente científica: Ciênc. Saúde Colet

Fecha de actualización: 6 Abril, 2022

Resumo O objetivo do estudo foi avaliar o impacto da pandemia de COVID-19 nos valores de vacinação para as imunizações voltadas a indivíduos com menos de um ano de vida no Brasil. Analisou-se os valores de cobertura vacinal, em território nacional, de dez vacinas presentes no calendário do Programa Nacional de Imunizações (PNI) durante os últimos oito anos (2013-2020). Esse é um estudo ecológico e todos os dados foram extraídos do PNI. Comparativamente aos anos prévios, em 2020 registrou-se o menor valor de cobertura vacinal da média do conjunto das vacinas estudadas, 75,07%, enquanto em 2019 esse mesmo índice ficou em 84,44%, resultando em uma queda de 11,10% entre esses dois períodos. Além disso, no ano da pandemia, das dez vacinas analisadas, nove registraram o seu menor valor histórico de cobertura, todas estando a no mínimo 14 pontos percentuais abaixo da meta do Ministério da Saúde. Embora já houvesse uma tendência de queda na cobertura vacinal, por diversos motivos, o presente estudo demonstra que os valores registrados em 2020 foram significativamente menores, fenômeno também registrado em outros países. Portanto, mesmo não conseguindo afirmar que a pandemia de COVID-19 e as medidas de distanciamento sejam as causas da queda dos valores de imunização, podemos inferir que há uma associação.

Abstract This study aimed to evaluate the impact of the COVID-19 pandemic on the vaccination numbers for immunization geared toward individuals under 12 months of age in Brazil. This study analyzed the numbers of the nationwide vaccination coverage of ten vaccines present in the calendar from the National Immunization Program (NIP) over the past eight years (2013-2020). This is an ecological study, and all data were taken from the NIP. In comparison to the previous years, 2020 recorded the lowest figures of vaccination coverage (VC) of the average of the group of studied vaccines - 79.07% - while in 2019, this same index was 84.44%, resulting in a drop of 11.10% between these two periods. Moreover, during the year of the pandemic, of the ten analyzed vaccines, nine recorded their lowest historical VC figures, all of which were at least 14 percentage points below the goals set by the Brazilian Ministry of Health (MS, in Portuguese). Although there had already been a tendency toward a decline in VC, for various reasons, the present study illustrates that the numbers recorded in 2020 were significantly lower, a phenomenon also reported in other countries. Therefore, although it is impossible to affirm that the COVID-19 pandemic and its distancing measures are the causes for the drop in the immunization numbers, it can be inferred that there is indeed an association.

Palabras clave: Cobertura vacinal, Distanciamento físico, Immunization programs, Physical distancing, Programas de imunização, Vaccination coverage


SPECIAL ARTICLE COVID-19: ENT Manifestations in Patients Suffering from COVID- 19: Study from a COVID Hospital in North India

Srivastava, Anitya; Dr. Ram Manohar Lohia Institute of Medical Sciences. Department of ENT. Lucknow. IN, Agarwal, Ashish Chandra; Dr. Ram Manohar Lohia Institute of Medical Sciences. Department of ENT. Lucknow. IN, Leer más
Alam, Syed Zeeshan; Dr. Ram Manohar Lohia Institute of Medical Sciences. Department of ENT. Lucknow. IN



Fuente científica: Int. arch. otorhinolaryngol. (Impr.)

Fecha de actualización: 6 Abril, 2022

Abstract Introduction COVID-19 has been one of the worst pandemics faced by the human civilization, and otorhinolaryngological manifestations are commonly seen in this disease. Objective The present study was done to profile the ear, nose, and throat (ENT) manifestations in patients diagnosed with COVID-19. An attempt has also been made to assess whether there was any difference between the symptoms of different strains of COVID-19. A brief review of the current knowledge of the transmission of the disease and its treatment has also been done. Methods A cross-sectional, record-based study was conducted in a COVID hospital of India between May and July 2020. Descriptive statistics were used and appropriate parametric/nonparametric tests were applied to assess the association between various variables. Results Out of 250 patients, 80 cases were asymptomatic and 170 were symptomatic. Most of the symptomatic patients had sore throat and nasal congestion. Conclusion Knowledge of the ENT manifestations of COVID-19 is essential for its early identification and to devise appropriate prevention protocols for the benefit of health care workers (HCWs) and of the general population.

Palabras clave: Covid-19, ENT, Otorhinolaryngology manifestations, Pandemic, SARS-COV-2


SPECIAL ARTICLE COVID-19: Safety for the Rhinologist in the Age of COVID-19: Mask Use, Nasal Corticosteroids, Saline Irrigation, and Endoscopic Procedures - Literature Review

Kosugi, Eduardo Macoto; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Villa, Jonatas Figueiredo; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Leer más
Ramos, Henrique Faria; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Luz-Matsumoto, Gabriela Ricci; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Serrano, Thiago Luis Infanger; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Campos, Carlos Augusto Correia de; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Barreto, Carolina Cincurá; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Lima, Clara Mônica; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Fornazieri, Marco Aurélio; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Piltcher, Otavio; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Lessa, Marcus Miranda; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR, Romano, Fabrizio Ricci; Academia Brasileira de Rinologia (ABR). Scientific Committee. São Paulo. BR



Fuente científica: Int. arch. otorhinolaryngol. (Impr.)

Fecha de actualización: 6 Abril, 2022

Abstract Introduction Coronavirus disease 2019 (COVID-19) has claimed millions of lives. Adequate protection of the professionals involved in patient care is essential in the battle against this disease. However, there is much uncertainty involving safety-relarted topics that are of particular interest to the rhinologist in the context of COVID-19. Objective To evaluate the current evidence regarding three safety-related topics: mask and respirator use, performance of nasal endoscopic procedures, and use of topical nasal and intranasal medications (saline irrigation and nasal corticosteroids). Methods A literature review was performed on the PubMed, Scopus, and Cochrane databases, with standardized search queries for each of the three topics of interest. Results In total, 13 articles on mask use, 6 articles on the safety of nasal corticosteroids, 6 articles on the safety of nasal endoscopic procedures, and 1 article on nasal irrigation with saline solution were included in the final analysis. Conclusion N95 respirators are essential for the adequate protection of otolaryngologists. If reuse is necessary, physical methods of sterilization must be employed. No evidence was found to contraindicate the use of nasal corticosteroids, whether acute (in the management of sinonasal inflammatory conditions) or continued (in patients who use them chronically). Nasal irrigation with saline solution apparently does not increase the risk in the context of COVID-19. Nasal endoscopic procedures should only be performed after testing the patient for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the surgical team must wear full personal protective equipment to prevent aerosol exposure.

Palabras clave: COVID-19, Corticosteroids, Masks, Nasal endoscopy, Nasal saline solution, Safety


Hearing Loss, Tinnitus, and Dizziness and their Relation with Covid-19: what is the Current Evidence?

Bento, Ricardo Ferreira; University of São Paulo. Hospital das Clínicas, Faculty of Medicine. Department of Ophthalmology and Otorhinolaryngology. São Paulo. BR, Campos, Tatiane Vacaro; University of São Paulo. Hospital das Clínicas, Faculty of Medicine. Department of Ophthalmology and Otorhinolaryngology. São Paulo. BR


Fuente científica: Int. arch. otorhinolaryngol. (Impr.)

Fecha de actualización: 6 Abril, 2022


SPECIAL ARTICLE COVID-19: Covid-19-Related Acute Invasive Fungal Sinusitis: Clinical Features and Outcomes

Abdelsamie, Alaa Mohamed; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Abdelazim, Hossam Mohamed; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Leer más
Elnems, Mohamed Goda; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Abdelhakam, Rehab Bassam; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Abdelalim, Abdelrahman Ahmed; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG



Fuente científica: Int. arch. otorhinolaryngol. (Impr.)

Fecha de actualización: 6 Abril, 2022

Abstract Introduction There is a noticeable increase in the incidence of acute invasive fungal sinusitis which coincides with the ongoing coronavirus pandemic. It is a potentiallylethal fungal infection, with the most common form being the rhino-orbito-cerebral presentation. Objectives The aim of the present study is to discuss the different epidemiological factors, risk factors, clinical presentations and outcomes of acute invasive fungal sinusitis which is noticeably related to the coronavirus disease 2019 (Covid-19) pandemic. Methods The present cross-sectional cohort study included 22 adult patients who presented with Covid-19-related acute invasive fungal sinusitis. The diagnosis of acute invasive fungal sinusitis was confirmed by histopathological biopsy. All data, including demographics, risk factors, clinical findings, different lines of treatment and their outcomes, were recorded and analyzed. Results All patients had diabetes mellitus (100%), and 17 (77.3%) had been submitted to systemic steroids. All patients (100%) had unilateral sinonasal disease. Proptosis was found in 15 patients (68.2%), ophthalmoplegia was observed in 12 patients (54.5%), and intracranial affection occurred in 10 patients (45.5%). A total of 20 patients (90.9%) received liposomal amphotericin B. Surgical debridement was performed in 18 patients (45.5%). Non-septated mycelia was present in 19 biopsies (86.4%), while 3 (13.6%) showed septated mycelia. Total improvement was achieved in 10 patients (45.5%), while the mortality rate was of 27.3% (6 out of 22 participants). Conclusion Diabetes mellitus is the most common preexisting medical condition associated with Covid-19-related acute invasive fungal sinusitis. Systemic corticosteroid therapy is considered a predisposing factor. It is necessary to raise the level of awareness to diagnose this condition, especially in patients with Covid-19 infection or those who have recently recovered from it.

Palabras clave: Covid-19, Mucormycosis, Sinusitis


Science Gender Gap: Are We in theRight Path?

Oliveira, Gláucia Maria Moraes de; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR, Tenorio, Marge; Tecnologia e Insumos Estratégicos do Ministério da Saúde. Departamento de Ciência e Tecnologia da Secretaria de Ciência. Brasília. BR, Leer más
Siqueira, Alessandra de Sá Earp; Tecnologia e Insumos Estratégicos do Ministério da Saúde. Departamento de Ciência e Tecnologia da Secretaria de Ciência. Brasília. BR



Fuente científica: Int. j. cardiovasc. sci. (Impr.)

Fecha de actualización: 6 Abril, 2022

Palabras clave: COVID-19, Cardiologists, Cardiovascular Disease, Ethics, Gender Identity, Pandemic, Women

Dia Mundial do Rim 2021 - vivendo bem com a doença renal: forças, fraquezas, oportunidades e ameaças durante a COVID-19
World Kidney Day 2021 - living well with kidney disease: strengths, weaknesses, opportunities and threats during COVID-19

Santos, Reginaldo Passoni dos; Universidade Estadual do Oeste do Paraná. Hospital Universitário. Departamento de Enfermagem. Cascavel. BR


Fuente científica: J. bras. nefrol

Fecha de actualización: 6 Abril, 2022

Tuberculose em tempos de COVID-19: não podemos perder o foco no diagnóstico
Tuberculosis in times of COVID-19: we cannot lose focus on the diagnosis

Torres, Pedro Paulo Teixeira e Silva; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR, Rabahi, Marcelo Fouad; Universidade Federal de Goiás. Goiânia. BR


Fuente científica: Radiol. bras

Fecha de actualización: 6 Abril, 2022